Search - tctmd.com

Displaying 41 - 60 of 94

Sort: Relevancy | Date

News Daily News

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

Shelley Wood

December 20, 2019

Presentation

Response by David Taggart, MD, PhD to the EXCEL Statement

Presenter: David Taggart

December 19, 2019

Taggart Rebuts EXCEL Response, Insisting on Retraction

News Daily News

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

Michael O'Riordan

December 18, 2019

News Features

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Michael O'Riordan

December 12, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

Presentation TCT 2019

Current Landscape and Future Directions: Intracardiac Shunts, Ventricular Remodeling Therapies

Presenter: Gregg Stone

September 25, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Todd Neale

July 04, 2019

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

Shelley Wood

March 14, 2019

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

News Daily News

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

Todd Neale

November 26, 2018

Presentation TCT 2018

Keynote Lecture: FDA/CDRH - The Year in Review

Presenter: Mitchell W. Krucoff, Gregg W. Stone, William H. Maisel

September 22, 2018

Presentation TCT 2018

The TCT FDA Town Hall Meetings in Perspective: A Multidisciplinary Collaborative Venture

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Martin B. Leon

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

Shelley Wood

August 28, 2018

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

Advertisement

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

Response by David Taggart, MD, PhD to the EXCEL Statement

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Current Landscape and Future Directions: Intracardiac Shunts, Ventricular Remodeling Therapies

What I Am Most Looking Forward to at TCT 2019

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

FDA Extends MitraClip Indication to Include Functional MR

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

Keynote Lecture: FDA/CDRH - The Year in Review

The TCT FDA Town Hall Meetings in Perspective: A Multidisciplinary Collaborative Venture

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content